Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ...

While dexamethasone, a commonly used corticosteroid, is a standard treatment for severe COVID-19, the study found that it modestly inhibited the release of arginase-1 from neutrophils. This was ...

The severe acute respiratory syndrome coronavirus 2 just keeps doing what it does oh-so-well: it just keeps mutating and mutating and mutating, resulting in more and more variants. Leading the ...

Known as human metapneumovirus (hMPV), this virus is one of the viruses that cause the common cold (upper respiratory ...